During the 1970s, Engel and his colleagues were the first to identify the role of the complement in the pathophysiology of MG by visualizing antibodies against AChR, C3, and MAC in the post-junctional membrane in patients with MG [27]. Here, C3 is linked to myasthenia gravis.